How Much Mobile Botox Owners Make: $467K Year 1 EBITDA Case
A mobile Botox business owner can model strong pre-tax income, but only if bookings, pricing, travel, staffing, and reserves hold In the base research case, Year 1 revenue is about $944k and EBITDA is $467k, before taxes, debt service, and owner distributions The founder salary is modeled at $120k per year, so true owner take-home depends on how much EBITDA is kept for cash, growth, and risk By Year 5, the researched case reaches $134M revenue and $107M EBITDA, but that assumes 35 injectors, higher capacity, and tight operating control
Owner income$587kNet margin31%Revenue for target pay$390kBusiness difficultyHard
Want to see what moves owner income most?
1
Appointment Volume
44/wk
More booked visits raise revenue first, and Year 1 runs about 44 visits a week across the injector mix.
2
Average Ticket
$409
The average ticket is about $409 in Year 1, so mix shifts to higher-priced visits move take-home fast.
3
Supply Waste
8.5%
Supplies and disposal run at 8.5% of revenue, so waste control drops straight to margin.
4
Routing Efficiency
11%
Travel and processing add about 11% of revenue, and tighter routing keeps more of each visit.
5
Fixed Load
$22K/mo
Founder pay, early staff, insurance, and admin set a roughly $22K monthly fixed load, so headcount choices shape breakeven.
6
Repeat Clients
2 mo
Repeat visits lower acquisition spend and lift conversion, which is why payback lands at about 2 months.
Want to test your owner income?
Owner income calculator
Estimate owner take-home and target-pay gap from revenue, margin, costs, reserves, and target pay.
!
Planning note: This is a researched planning estimate only, not guaranteed salary, tax advice, or owner distribution advice. Actual owner income depends on revenue, margins, payroll, taxes, reserves, and cash timing.
Want to test owner income in the Mobile Botox Service model?
Yes—Mobile Botox Service can scale profitably in the model, but only if provider capacity and route density keep up. Revenue rises from $944k in Year 1 to $1.344M in Year 5 as injector count grows from 5 to 35, while EBITDA climbs from $467k to $1.069M. The catch is operational: Year 5 payroll hits $475k, you need at least $875k in cash if the owner keeps injecting, and the calendar can become the bottleneck before demand does.
Scale drivers
5 to 35 injectors expands reach
Revenue grows to $1.344M by Year 5
EBITDA reaches $1.069M
Repeat demand must stay high
Key risks
Owner injecting can cap capacity
Payroll rises to $475k in Year 5
Needs $875k minimum cash reserve
Route density and oversight cost can bite
Do mobile Botox owners make more if they inject?
Yes, Mobile Botox Service owners can make more early if they inject, because the owner replaces some hired provider labor and protects margin; What Is The Most Important Metric To Measure The Success Of Your Mobile Botox Service? explains why utilization still drives the economics. The modeled plan is not a pure solo-injector case: it includes a $120,000 CEO founder salary plus hired injector capacity.
Owner injects
Raises early take-home income
Replaces some provider labor
Protects service margin
Limits owner sales time
Owner scales
5 injectors in Year 1
35 injectors in Year 5
7x capacity growth
Adds payroll and oversight
How many Botox appointments per week to make money?
For Mobile Botox Service, the Year 1 model points to about 2,310 completed appointments, or roughly 44 per week. Here’s the quick math: that uses 3 RN injectors at 60 monthly treatments and 60% capacity, plus 1 NP and 1 PA at 65 monthly treatments and 65% capacity. At an average ticket of about $409, break-even to cover $264k of modeled fixed overhead, non-founder payroll, and $120k founder salary is about 15 visits per week at about $329 contribution per visit.
Volume
2,310 annual visits
44 visits per week
3 RN injectors modeled
60% RN capacity
Break-even
$409 average ticket
$329 contribution per visit
15 visits per week to break even
No-shows and drive time lift volume needs
Key Takeaways
More completed appointments drive income only when routes stay dense.
Average ticket gains matter because volume is already high.
Product waste cuts gross profit fast, even with strong revenue.
Fixed costs and repeat clients decide monthly take-home.
Compare lean, base, and high owner-income cases
Owner income scenarios
Owner income rises with injector count, treatment volume, and pricing, but payroll and overhead also rise as the service scales.
Low, base, and high cases show how staffing and capacity change owner earnings.
Scenario
Low CaseReserve risk
Base CaseHiring complexity
High CaseCapacity risk
Launch model
This is the lower earnings path, where the launch year stays near first-year scale.
This is the modeled middle path, built around the Year 3 injector mix and steadier volume.
This is the stronger earnings path, where the Year 5 operating plan pushes close to the top of the model.
Typical setup
Year 1 runs 5 injectors, about $1.52M annual revenue, and $467k EBITDA after founder salary, support staff, and overhead.
Year 3 runs 17 injectors, about $6.32M annual revenue, and $3.465M EBITDA as management, payroll, and systems scale.
Year 5 runs 35 injectors, about $15.73M annual revenue, and $10.685M EBITDA with heavier management load and tighter capacity use.
Cost drivers
Injector count
treatment volume
pricing mix
fixed payroll
travel and commissions
Injector count
monthly treatments
price mix
support payroll
medical supplies
Injector count
treatment volume
higher ticket mix
management payroll
capacity use
Owner income rangeBefore owner reserves
$467kYear 1 scale
$3.5MYear 3 scale
$10.7MYear 5 scale
Best fit
Use this to test launch demand and reserve needs if hiring or bookings ramp slowly.
Use this as the core planning case for staffing, process, and cash planning.
Use this to test hiring bottlenecks, reserve needs, and what happens if demand keeps outpacing staff growth.
!
Planning note: These scenario figures are researched planning assumptions, not guaranteed earnings, salary promises, tax advice, or distributions.
Mobile Botox Service Core Six Income Drivers
Appointment Volume And Utilization
Appointment Volume And Utilization
More completed appointments usually lift owner income because revenue rises faster than travel and labor when the calendar stays full. In the model, Year 1 capacity is 600% for RN injectors and 650% for NP and PA injectors, then moves to 850% and 880% by Year 5. The key inputs are booked visits, completed visits, provider mix, and route density.
Fixed costs stay at $6,600 per month, so cancellations, no-shows, and underfilled days hit profit fast. A light calendar still carries the same medical director, insurance, software, and admin burden, which cuts cash available for owner draw. One empty day can matter more than one lower-price visit if travel time also goes unpaid.
Protect Utilization
Track booked appointments, completed appointments, cancellation rate, no-show rate, and drive time per visit. Use those numbers to forecast monthly contribution before payroll and overhead. If completed visits fall, owner income falls with them unless the schedule gets denser or the service radius gets tighter.
Block routes by zip code.
Require clear booking rules.
Confirm visits before dispatch.
Watch underfilled days weekly.
Dense routes help because two nearby visits can beat three scattered ones when drive time blocks the next paid slot. That matters most once fixed costs are already in place, since the business needs each day to carry enough completed appointments to support owner pay.
Travel Density And Scheduling Efficiency
Travel Density
When visits are clustered, the owner keeps more of the day billable. In this model, travel sits inside practitioner commissions at 85% of Year 1 revenue and 70% by Year 5, so every unpaid gap between clients hits take-home fast. Dense routes protect capacity; scattered bookings turn paid time into drive time.
The inputs are simple: appointments per route, drive minutes between clients, service radius, and cancellations. Two nearby clients can beat three scattered ones if travel blocks another paid visit. With $6,600 a month in fixed overhead, route waste drops profit even before labor or product costs change.
Keep Routes Tight
Track paid visits per route hour and unpaid drive minutes per day. If one extra stop requires a long cross-town trip, narrow the service area or tighten booking windows so the day stays stacked. A fuller route usually helps owner pay more than a wider map with more empty miles.
Measure drive minutes between every visit.
Cap gaps that block another appointment.
Test tighter zip codes first.
Price long routes for lost capacity.
Watch the tradeoff: a bigger radius can look like growth, but if it cuts daily capacity, the owner earns less per clinician hour. The best routing plan is the one that keeps commissions tied to completed visits, not windshield time.
Average Ticket And Service Mix
Average Ticket And Service Mix
Blended average ticket, meaning total service revenue divided by completed appointments, is about $409 across the modeled mix, with RN visits at $400, NP and PA visits at $420, and later MD visits at $530 to $550. With 2,310 completed appointments, that lands near $944,790 in annual revenue. One clean rule: small price shifts matter when volume is fixed.
This driver includes the price per visit and the provider mix behind it. If the mix shifts toward lower-priced RN work, the same setup time, acquisition cost, and travel cover less revenue, so owner take-home gets squeezed. Higher-ticket visits support margin only when the calendar stays full and cancellations stay low.
Track Blended Price By Provider Mix
Measure monthly blended ticket as total service revenue divided by completed appointments, then split it by provider type. Watch whether the calendar leans too hard on $400 RN visits or keeps enough $530 to $550 MD work to lift the average. At 2,310 visits, every $10 change in ticket moves annual revenue by about $23,100.
Track completed appointments.
Track provider mix by type.
Track price per visit.
Use that mix to forecast cash flow and owner draw. If volume stays flat but the blend drops, profit falls fast because travel and setup do not shrink with the ticket. If pricing rises without hurting booking, the business keeps more cash after labor and can pay the owner more.
Labor, Oversight, Insurance, And Fixed Costs
Fixed Overhead And Payroll
This driver is the monthly fixed nut: overhead plus payroll before any owner draw. In the model, overhead is $6,600 per month or about $79,200 a year, including a $3,000 medical director retainer, $1,500 liability insurance, $800 booking and electronic medical record software, and smaller admin items. That cost runs even when the calendar is light, so it directly trims cash available for owner pay.
Payroll is the bigger swing. It starts at $185k in Year 1 and reaches $475k in Year 5. Hiring providers can raise capacity, but it also adds scheduling, supervision, training, and compliance work. If appointment volume does not rise fast enough, labor eats margin before the owner can pay themselves.
Track Labor And Overhead Weekly
Estimate this driver with four inputs: provider count, payroll, fixed overhead, and booked appointments. The key question is simple: can each added provider cover their wage plus the $6,600 monthly base? If not, the business gets busier without getting more profitable.
Track payroll as a % of revenue.
Separate fixed vs. semi-fixed costs.
Watch admin time per provider.
Keep staffing tied to booked demand, not hope. Dense schedules lower wasted labor hours, and weak utilization makes supervision and compliance cost more painful. No state-specific legal advice here; the financial test is whether new labor adds enough collected revenue to lift owner take-home after all recurring costs.
Repeat Clients And Marketing Efficiency
Repeat Clients And Referrals
More repeat bookings mean less cash spent replacing lost demand. In this model, marketing is budgeted at 0.5 FTE on a $60k annual role in Year 1, then rises to 1.0 FTE from Year 3 onward. Client success starts in Year 2 at $50k and reaches 2.0 FTE in Year 5.
Stable rebooking supports higher capacity assumptions and steadier cash flow because the calendar refills with less paid acquisition. Weak retention forces more spend to replace each lost client, which cuts operating profit and can squeeze owner pay even when bookings look busy.
Track Rebook Rate And Referral Share
Measure rebook rate and referral share, then compare them with the cost to book each visit. If retention improves, the model can hold the planned 0.5 FTE to 1.0 FTE marketing path instead of drifting higher, which protects margin and leaves more cash for owner draws.
Track rebook rate by provider.
Track referral share monthly.
Track paid booking cost.
Track client success workload versus FTE.
Build rebooking into the visit flow before the client leaves. If repeat visits slip, treat it like a margin leak, because you’ll need more client success labor and more paid demand to keep the schedule full, and those costs hit profit before revenue grows.
Product Cost And Inventory Waste
Product Cost and Waste
Product and medical waste sit in cost of goods sold, not overhead or owner pay. In the model, Year 1 neurotoxin and supplies are 80% of revenue and waste is 5%; at about $94.4k in Year 1 revenue, that’s roughly $80k in product cost before any labor or fixed overhead. That means gross profit per appointment gets squeezed fast if vials are opened too early or used poorly.
By Year 5, the combined rate falls to 63%, or about $847k on $1.344M revenue. That still leaves a big cash drain if demand planning is weak. Here’s the quick math: every wasted unit lowers margin, and lower margin means less cash left for taxes, debt, and the owner’s draw.
Control Vials and Waste
Track product use by appointment, vial, and reorder date. Watch the share of revenue spent on supplies and waste each month, then compare it to the model’s 80% Year 1 and 60% Year 5 product cost rates. If waste creeps above 5% in Year 1 or 3% in Year 5, gross profit per visit starts falling before revenue does.
Order from booked demand, not hope. Poor vial use and weak demand planning turn paid inventory into dead cash, which hits owner income twice: first in lower gross profit, then in slower cash conversion. One clean rule helps: only open product when the schedule is dense enough to use it.
